TrianglePUBLICATIONS · 20850381
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2010 Oct
- First author
- Lipshultz SE
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Lipshultz SE
- type
- Author
- name
- Scully RE
- type
- Author
- name
- Lipsitz SR
- type
- Author
- name
- Sallan SE
- type
- Author
- name
- Silverman LB
- type
- Author
- name
- Miller TL
- type
- Author
- name
- Barry EV
- type
- Author
- name
- Asselin BL
- type
- Author
- name
- Athale U
- type
- Author
- name
- Clavell LA
- type
- Author
- name
- Larsen E
- type
- Author
- name
- Moghrabi A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Lipshultz SE
- type
- Author
- name
- Scully RE
- type
- Author
- name
- Lipsitz SR
- type
- Author
- name
- Sallan SE
- type
- Author
- name
- Silverman LB
- type
- Author
- name
- Miller TL
- type
- Author
- name
- Barry EV
- type
- Author
- name
- Asselin BL
- type
- Author
- name
- Athale U
- type
- Author
- name
- Clavell LA
- type
- Author
- name
- Larsen E
- type
- Author
- name
- Moghrabi A
- type
- Author
- bibliography ids
- nci-bib-862f23865e1f0c6693f2dd52
- book metadata
- content sha256
- 9e430cf4edb6ee82a32b3bdf261416a3e8d7b07c57bfd0ad4a13be500e08412f
- document type
- citation
- dois
- 10.1016/S1470-2045(10)70204-7
- electronic publication date
- display
- 2010 Sep 16
- precision
- day
- year
- 2010
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:20850381
- immutable id
- pubmed:20850381@9e430cf4edb6ee82a32b3bdf261416a3e8d7b07c57bfd0ad4a13be500e08412f
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 10
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 950-61
- volume
- 11
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 20850381
- provenance
- batch id
- 10a38257e12e9ed1867a
- provider
- NCBI PubMed ESummary
- record sha256
- 54c995e0e1846e44a79ebb8de4141912a3a50f88b561c8e9abebe142d204d8f5
- response sha256
- 84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
- retrieved at
- 2026-09-09T23:46:35.793530+00:00
- publication date
- display
- 2010 Oct
- precision
- month
- year
- 2010
- publication types
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.
Preserved source evidence · Not medical advice